Table 1 Characteristics of studies included for meta-analysis. Cut-off value: median expression
From: The expression profile and clinic significance of the SIX family in non-small cell lung cancer
First author | Year | Duration (months) | Histology | Stage | Patient number | Quality score | Detection | Platform |
|---|---|---|---|---|---|---|---|---|
Okayama H [41] | 2011 | 120 | ADC | I–II | 226 | 9 | Microarray | Affymetrix Hgu133plus2.0 |
Hou J [42] | 2010 | 130 | NSCLC | NR | 91 | 9 | Microarray | AffymetrixHgu133plus2.0 |
Tang H [43] | 2013 | 120 | NSCLC | I–III | 176 | 9 | Microarray | IlluminaHumanWG-6v3.0 |
Zhu CQ [44] | 2010 | 108 | NSCLC | IB–II | 133 | 9 | Microarray | AffymetrixHgu133a |
Raponi M [45] | 2006 | 144 | SQC | I–III | 129 | 8 | Microarray | AffymetrixHgu133plus2.0 |
Bild AH [46] | 2006 | 88 | NSCLC | NR | 111 | 8 | Microarray | AffymetrixHgu133plus2.0 |
Rousseaux S [47] | 2013 | 256 | NSCLC | I–IV | 293 | 9 | Microarray | AffymetrixHgu133plus2.0 |
Tomida S [48] | 2009 | 109.8 | ADC | I–III | 117 | 9 | Microarray | AgilentWholeHumanGenomeMicroarray 4x44K G4112F |
Botling J [49] | 2013 | 120 | NSCLC | I–IV | 196 | 8 | Microarray | AffymetrixHgu133plus2.0 |
Shedden K [50] | 2008 | 204 | ADC | I–IV | 333 | 9 | Microarray | AffymetrixHgu133a |
Beer DG [51] | 2002 | 110.6 | ADC | I–III | 86 | 8 | Microarray | AffymetrixHumanFullLength HuGeneFL |
Landi MT [52] | 2008 | NR | ADC | I–IV | 74 | 9 | Microarray | AffymetrixHgu133a |
Lu T [53] | 2010 | NR | ADC | I–IV | 60 | 8 | Microarray | AffymetrixHgu133plus2.0 |
Lee ES [54] | 2008 | 120 | NSCLC | I–III | 138 | 8 | Microarray | AffymetrixHgu133plus2.0 |
Kuner R [55] | 2009 | NR | NSCLC | NR | 58 | 8 | Microarray | AffymetrixHgu133plus2.0 |
Selamat SA [56] | 2012 | NR | ADC | I–III | 58 | 8 | Microarray | IlluminaHumanWG-6v3.0 expression |
Meyerson M [57] | 2015 | NR | SQC | I–IV | 135 | 8 | Microarray | AffymetrixHgu133a |